The FDA granted orphan designation to Janssen Research & Development’s bleximenib as a treatment of acute myeloid leukemia, according ...

During my second trimester of pregnancy, I started to notice a weird rash, which led to other events before my diagnosis of ...

In the clinical battle against leukemia, recent breakthroughs in chimeric antigen receptor T cells (CAR T) have given ...

Leukemia stem cells (LSCs) pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to ...

The Hunter Gerdes Memorial Golf Outing is an annual testament to one family and one community's devotion to all children ...

Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...

A new classification model called AML60+ improved risk stratification for older adults with acute myeloid leukemia, which can ...

A 6 year old arkansan battling leukemia was recognized at the 6th annual lift againt leukemia today.T-cell acute ...

(Nasdaq: MBRX) ("Moleculin" or the "Company"), a late stage pharmaceutical company with a broad portfolio of drug candidates ...

The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML ...